Read More Healthcare Industry News Why Femasys’ FDA-cleared next-generation FemVue device could reshape non-radiation fertility diagnostics in the U.S. Find out how Femasys’ FDA-cleared next-generation FemVue device could reshape non-radiation fertility diagnostics and influence the U.S. women’s health market today. bySoujanya RaviDecember 18, 2025